There are plenty of reasons for investors to like big pharma stocks. They're usually resilient during economic downturns. Many of them have solid growth prospects. And nearly all of them pay dividends.
AbbVie (NYSE: ABBV) and Merck (NYSE: MRK) rank as two of the biggest of the big pharmaceutical companies. These two companies face unique challenges and opportunities. But which is the better pick for long-term investors?
Image source: Getty Images.
Source Fool.com